4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000012
GENERAL COUNSEL & CORP SEC sold 2,861 shares at an average $32.03 ($91,639)
- GENERAL COUNSEL & CORP SEC acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Allan Jonathan · GENERAL COUNSEL & CORP SEC
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-14 | Exercise or conversion : show line 1 in the form | +6,000 | 24,086 | D | ||
| 2026-08-18 | Sale : show line 2 in the form | −2,716 | $32.01 | $86,932 | 21,370 | D |
| 2026-08-18 | Sale : show line 3 in the form | −145 | $32.47 | $4,708 | 21,225 | D |
| Open-market sales · 2,861 sh · avg $32.03 · $91,639 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-14 | Exercise or conversion : show line 4 in the form Performance Stock Units | −6,000 | 0 | D |
Loading xslF345X06/form4-08192026_120818.xml…